63484-12-8 Usage
Description
Methyl 2-methoxy-5-methylsulfonylbenzoate is an organic compound with the molecular formula C9H10O5S. It is characterized by the presence of a benzene ring with a methoxy group at the 2nd position and a methylsulfonyl group at the 5th position, with a methyl ester group attached to the benzene ring. Methyl 2-methoxy-5-methylsulfonylbenzoate is known for its potential applications in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
Methyl 2-methoxy-5-methylsulfonylbenzoate is used as an impurity in the production of Tiapride (T437050), a D2 and D3 dopamine receptor antagonist and an antipsychotic drug. It is predominantly utilized in the pharmacotherapy of patients with dementia, where it helps in managing the symptoms and improving the overall quality of life for the patients.
Methyl 2-methoxy-5-methylsulfonylbenzoate's role as an impurity in the production of Tiapride highlights its importance in the pharmaceutical industry, as it contributes to the development and effectiveness of the antipsychotic drug. By understanding the properties and applications of Methyl 2-methoxy-5-methylsulfonylbenzoate, researchers and pharmaceutical companies can continue to explore its potential uses and optimize its integration in the development of new drugs and therapies.
Flammability and Explosibility
Notclassified
Check Digit Verification of cas no
The CAS Registry Mumber 63484-12-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,4,8 and 4 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63484-12:
(7*6)+(6*3)+(5*4)+(4*8)+(3*4)+(2*1)+(1*2)=128
128 % 10 = 8
So 63484-12-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O5S/c1-14-9-5-4-7(16(3,12)13)6-8(9)10(11)15-2/h4-6H,1-3H3
63484-12-8Relevant articles and documents
SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT ALLERGIC DISEASES
-
, (2008/06/13)
The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4] diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
Novel substituted 4-(1H-benzimidazol-2-yl) [1,4]diazepanes useful for the treatment of allergic diseases
-
, (2008/06/13)
The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
